CA2212601A1 - Analyte concentration measurement using a hollow frustum - Google Patents

Analyte concentration measurement using a hollow frustum

Info

Publication number
CA2212601A1
CA2212601A1 CA002212601A CA2212601A CA2212601A1 CA 2212601 A1 CA2212601 A1 CA 2212601A1 CA 002212601 A CA002212601 A CA 002212601A CA 2212601 A CA2212601 A CA 2212601A CA 2212601 A1 CA2212601 A1 CA 2212601A1
Authority
CA
Canada
Prior art keywords
meter
sample
analyte
membrane
disposable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002212601A
Other languages
French (fr)
Inventor
Jerry Thomas Pugh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LifeScan Inc
Original Assignee
LifeScan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LifeScan Inc filed Critical LifeScan Inc
Publication of CA2212601A1 publication Critical patent/CA2212601A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L99/00Subject matter not provided for in other groups of this subclass
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/508Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • G01N33/528Atypical element structures, e.g. gloves, rods, tampons, toilet paper

Abstract

A method for measuring the concentration of an analyte in a sample of a biological fluid involves a hollow, frustum-shaped disposable device. The smaller end of the frustum has a porous membrane, to which the sample is applied. Preferably, a reagent in the membrane reacts with the analyte to cause a color change. The device is mounted on a meter, which measures the color change and computes from the change the analyte concentration in the sample.
Preferably, the devices are released from the meter without touching them, to protect against contamination.

Description

~AT YT~ C()NC~TION M~SIJR~ TSI~(~
A HOT.T OW FR~ ~STr JM

S B~kgrotlnrl of the Tnv~ntion 1. Fiel~l of t~le Tnv~ntion This invention relates to a meter and disposable device for measuring the concentration of an analyte in a biological fluid; more particularly, an apparatus for which the disposable device is a hollow frustum.
2. nescription of tl~e R~lAte~l ~rt Medical diagnosis often involves measurements on biological fluids, such as blood, urine, or saliva, that are taken from a patient. Generally, it is lS important to avoid both contamination of equipment and personnel with these fluids and to avoid contamination of the patient with fluids from others. ~us, there is a need for diagnostic devices that minimize the risk of such contamination.
Among the medical diagnostic devices that are in most widespread use today is the blood glucose monitor. In the U.S. alone, there are an estimated 14million people with diabetes. In order to avoid serious medical problems, such as vision loss, circulatory problems, kidney failure, etc., many of these peoplemonitor their blood glucose on a regular basis and then take the steps necessaryto maintain their glucose concentration in an acceptable range.
Blood contamination is of concern when making a blood glucose measurement. For example, when using the most common types of whole blood glucose meters (photometric), the glucose determination is generally made from a blood sample that is applied to a test strip that is on the meter. To apply the patient's finger-stick blood sample, the patient's finger must be positioned above and near to the test strip in order to inoculate the test stripwith the blood sample. There is a risk that the patient's finger may come into contact with a portion of the meter that is contaminated with blood from previous use by others, particularly when used in a hospital.
This risk to the patient is minimized if the test strip is inoculated before it is placed into the meter. This is the so called "off-meter dosing" approach.
With this approach, the patient applies his blood sample to a reagent test stripas the first step in the measurement process. Then the strip is inserted into the meter. The patient's finger only comes into contact with a new (clean) disposable, which cannot be contaminated by another patient's blood. The finger never comes into contact with a contaminated portion of the meter. The approach of off-meter dosing has been used for some time, particularly with meters that operate photometrically, as well as in systems that measure hematocrit. A disadvantage of off-meter dosing is that the meter cannot take a measurement at or before "time-zero", the time when the sample was applied to the strip. In a photometric meter, a reflectance reading prior to strip inoculation permits the meter to correct for variations in strip background color and positioning. The meter can also determine time-zero more directly and more accurately, which facilitates accurate measurements. By contrast, time-zero may be difficult or impossible to determine if the strip is inoculated off-meter.
Although off-meter dosing reduces the contamination problem for the patient, the meter can still become contaminated with blood. There is thus a risk to others who may come into contact with the contaminated meter, such as workers in a hospital and meter repair technicians. Furthermore, if the patient is being assisted by a healthcare worker, that worker could come into contact with the patient's blood while removing the strip for disposal, after the test has been completed.
Meters that operate electrochemically typically use "remote dosing", in which the test strip is placed in the meter before inoculation, but the blood application point is remote from the meter surfaces that can become contaminated. For example, the Glucometer Elite(~) from Bayer Diagnostics and the Advantage~ from Boehringer Mannheim incorporate electrodes with remote sample application. As with off-meter dosing, strip removal may also pose a risk for meters that use remote dosing.
A number of systems have been disclosed that are aimed at reducing the risk of contamination to a patient and/or to others in connection with lS diagnostic tests.
U.S. Pat. 4,952,373, issued August 28, 1990, to Sugarman et al., discloses a shield that is designed to prevent excess liquid on diagnostic cartridges from being transferred to a monitor with which the cartridge is used. The shield is fabricated from thin plastic or metallic film and is attached to a cartridge that is generally the size of a credit card.
U.S. Pat. 5,100,620, issued March 31, 1992, to Brenneman, discloses an inverse funnel shaped body with a central capillary tube to transport a liquid sample from a remote sample-application point to a test surface. The device can be used to transfer blood from a finger stick to a reagent film.
U.S. Pat.3,991,617, issued November 16,1976, to Marteau d'Autry discloses a device that is used with a pipette intended to be used with disposable tips. -The device provides a push button mechanism for ejecting the tip from the end of the pipette.
The common element of the above patents is that each of the devices disclosed addresses the risk of contamination that is posed by biological fluidsS and other poterltially hazardous liquids.

- Summ~ry of the Tnv~ntion In accordance with the present invention, a device for use in an apparatus for measuring a concentration of an analyte in a sample of a biological fluid comprises (a) a hollow frustum, having open ends of unequal size and (b) a porous membrane for acce~t~~~g the sarnple, attached to, and substantially closing, the smaller open end, the membrane comprising (i) a surface for acceyt..~g the sample and (ii) a reagent for reacting with the analyte to cause, in a physically detectable parameter of the membrane, a change that can be measured and be related to the concentration of the analyte in the sample.
A method of this invention for measuring a concentration of an analyte in a sample of a biological fluid comprises (a) providing a device that comprises a hollow frustum having open ends of unequal size, whose smaller end is substantially closed by a membrane that has (i) a surface for accepting the sample and (ii) a reagent for reacting with the analyte to cause, in a physically detectable parameter of the membrane, a change that can be measured and be related to the concentration of the analyte in the sample;

(b) applying the sample to the membrane surface;
(c) measuring the change in the parameter; and (d) determining the analyte concentration from the measurement of the parameter change.
The device of the present invention can be used advantageously with a meter for measuring a concentration of an analyte in a sample of biological fluid that is applied to a first surface of a porous membrane that contains a reagent, which reacts with the analyte to cause a change in reflectance of a second surface of the membrane, the membrane being attached to and substantially closing an end of a hollow frustum device. The meter comprises (a) a body having a frustum-shaped distal section for mating engagement with the device, the section tapering inwardly to an end that faces the second surface of the membrane, (b) an optical system in the body to direct a beam of light out from the distal end and to accept light reflected back from the second surface of the membrane, (c) means for measuring the light reflected back into the body both before and after the sample is applied to the membrane, and (d) means for computing the analyte concentration in the fluid from the measured values of reflected light.
The device of the present invention permits a person to measure the analyte concentration in a biological fluid, while minimizing the risk that the fluid or the user will come into contact with the measurement apparatus. Thus, the device reduces both the likelihood of contamination of the apparatus by the user and vice versa. The device is disposable, and the terms "device" and "disposable" are used interchangeably throughout this specification and the appended claims.

BriPf T)es--ripti~ n of th~ nr~wir~gs Fig. 1 is a perspective view of a device of this invention with a portion broken away for clarity;
Fig. 2 is a cross-sectional view taken along line 2-2 of Fig. 1;
Fig. 3 is a perspective view of a meter and device of the invention prior to their being attached;
Fig. 4 is a perspective view of the meter and device in the process of obtaining a blood sample;
Fig. 5 is a partial cross-sectional view of the meter and device of Fig. 4, taken along line 5-5 of Fig. 4;
Fig. 6 is a side view in partial cross section of a plurality of devices in a package;
Fig. 7 is a perspective view of a meter of this invention ejecting a device;
Fig. 8 is a longitudinal cross section, with certain parts in elevation for clarity, of the meter of Fig. 7 in a first, in-use position;
Fig. 9 is a side elevational view, partially in cross section, of the meter of Fig. 7 in a second, ejection, position;
Fig. 10 is a perspective view of an alternate embodiment of a meter;
Fig. 11 is a perspective view of an alternate embodiment of a device of this invention;
Fig. 12 is a fragmentary perspective view of the distal end of the device of Fig. 11;
Fig. 13 is a cross-sectional view taken along line 13-13 of Fig. 12;

Fig. 14 is a cross-sectional view taken along line 14-14 of Fig. 12;
Fig. 15 is a cross-sectional view of a further embodiment of the distal end of a device of the invention;
Fig. 16 is a perspective view of another embodiment of a meter and device S prior to their being attached;
Fig. 17 is another embodiment of a meter and device;
Fig. 18 is a perspective view of the distal end of a further embodiment of the meter and device;
Fig. 19 is a side view of the distal end of the meter and device of Fig. 18 shown in an assembled position.
net~ile~ nes~ ription of th~ Tnv~ntion The device of the present invention is generally adapted for use in an apparatus for measuring the concentration of analytes, such as alcohol, cholesterol, ~roteills, ketones, enzymes, phenylalanine, and glucose, in biological fluids such as blood, urine, and saliva. For brevity, we describe thedetails for using the device in connection with self-monitoring of blood glucose; however, a person of ordinary skill in the art of medical diagnostics - would be able to readily adapt the technology for measuring other analytes in other biological fluids.
2n Self-monitoring of blood glucose is generally done with meters that operate on one of two principles. The first is the photometric type, which is based on reagent strips that include a composition that changes color after blood is applied. The color change is a measure of the glucose concentration.
The second type of blood glucose monitor is electrochemical and operates on the understanding that blood applied to an electrochemical cell can cause an electrical signal - voltage, current, or charge, depending on the type of meter -that can be related to the blood glucose concentration.
The present invention permits convenient, remote dosing for both photometric and electrochemical systems. For brevity, the description below S focuses on a photometric system. Similar devices can be used with an electrochemical system. With either type of system, the present device permits the meter to monitor the complete course of the reaction, from the time the sample is applied until a glucose determination is made. The ability to measure the test start time makes it easier to determine the glucose 10 concentration accurately.
There are some advantages to using a photometric rather than an electrochemical system to make a glucose determination. One advantage of a photometric system is that measurements can be made at more than one wavelength of light, and corrections can be made for variations in blood 15 hematocrit. The disposable disclosed here provides these advantages of the photometric system, while also permitting minimal meter contamination.
The disposables used in photometric measurement systems are generally made in the form of a thin rectangular strip. The shape derives from the original so- called "dip and read" test strip configuration. One end serves as a20 handle, while the chemical reaction with the fluid sample is carried out at the other end.
These rectangular disposables form the male portion of the interface with the meter. That is, the strip is retained by features on the meter that enclose the disposable. This method of retention invites contamination of the meter with 25 the fluid sample.

In order to avoid the problems of contamination the present disposable takes the form of a hollow frustum, which provides the female portion of ~e interface with the meter. That is, the disposable encloses a portion of the meter and serves as a cover to prevent contamination of the meter by the fluid S sample.
Fig. 1 depicts in partial cutaway an embodiment of this invention in which the disposable 10 is a hollow frustum of a cone. Membrane 12 is attached to the smaller end 14. Optional lip 16 provides a surface to which membrane 12 is attached with adhesive 18. Optional indentations 20 are l0 spaced around the circumference of the cone to provide a retention mechanism, in conjunction with a groove on a meter.
Fig. 2 is a cross section of the disposable of Fig. 1 taken along the line 2-2. As shown in Fig. 2, the membrane is attached to the outside of the disposable. Alternatively, as shown in Fig. 11, the membrane may be attached lS to the inside of the disposable.
Fig. 3 is an exploded perspective view of a photometric meter and a disposable device of the type shown in Fig. 1. Meter 30 has an elongated configuration with a distal section 32 that is a substantially cylindrically symmetrical frustum, along whose perimeter is optionally a groove 34. Note 20 that the disposable nests on the distal section of the meter in such a way that there is an accurately defined gap G between the distal end 36 of meter 30 and the bottom surface of membrane 12. The accurate positioning contributes to measurement precision and reliability. In the cutout can be seen a light source 38 and detector 40, which provide for illuminating a disposable and for 25 detecting light reflected from the disposable, respectively. As discussed below, measuring light reflected from the disposable yields the glucose concentration ~ CA 02212601 1997-08-06 in the sample applied to the membrane. Although only one source and detector are shown in Fig. 3, multiple sources, optionally having differellt output spectra, and/or multiple detectors may be used.
Fig. 4 is a perspective view of the way in which a device and meter of Fig.
3 can be used to obtain a sample S from a stuck finger tip. It is quite easy forthe user to bring the disposable into contact with the finger, which is a big advantage for users that have impaired vision.
Fig. 5 is a cross section of part of distal section 32 of meter 30 and disposable 10, which illustrates the way indentations 20 and groove 34 positively locate meter 30 within disposable 10, leaving gap G. Note that gap G
ensures that blood that penetrates through the membrane does not contaminate the meter. The gap dimension, while not critical, is preferably at least about lh mm.
An advantage of the device of the invention, when used with a meter of lS the type shown in Fig.3, is that the devices can be in a stack, nested conveniently in a container 42, as shown in Fig. 6. A device can then be secured simply by inserting the distal section 32 of meter 30 into container 42 and engaging groove 34 and indentations 20. After a test has been completed, a used disposable can be ejected into waste container W, as shown in Fig. 7, provided there is an optional push-button ejection mechanism.
Push-button ejection mechanisms of the type that are widely known and used are suitable for this invention (see e.g.; U.S. Pat.3,991,617). One such mechanism is depicted in Figs. 8 and 9, which show a push-button mechanism mounted in a meter of the type shown in Fig.3. The elements of the mechanism include shaft 44, which joins ejector 46 and push button 48. Push button 48 works through shaft 44 to cause ejector 46 to disengage disposable 10 from the distal section 32 of meter 30. Spring 50 works to return the ejector 46and push button 48 to their retracted position. Push-button ejection, by permitting the disposable to be removed without direct contact, helps to avoid contamination. Disposables to be used with push-button ejection mechanisms S of the type shown in Figs. 8 and 9 ~refe~ably have a flange 19.
Fig. 10 depicts an embodiment of a meter of this invention, which includes a display 50 for depicting the analyte concentration measured by the meter. The display can be a light-emitting diode (LED) display, a liquid crystaldisplay (LCD), or similar display well known in the art.
Although the above description and Figs. contemplate a disposable having a circular cross section and meter having a distal section having a mating cross section, that geometry is not essential and, in fact, may not even be ~refelled. A primary consideration in selecting the geometry in a photometric system is the optical design. Generally, reflectometry dictates at least a minimum angular separation (typically 45~) between a detector and specularly reflected light. This, in turn requires at least a minimum vertex angle of the conical disposable. However, it is an advantage to a user to be able to view his/her finger for dosing, and a large vertex angle intef~res with that view. Thus, a disposable having a rectangular cross section may be ~refelled, such as the hollow frustum of a rectangular pyramid 110 shown in Fig. 11. In that case, the arlgular separation between detector and specular-reflected lightdetermines only the minimum feasible value of L, the longitudinal dimension of the larger open end. But the disposable could be smaller and provide less interference with a user's view of his/her finger. Furthermore, rectangular membranes can be fabricated from ribbons or sheets at less expense and with LFS~58 - CA 022l260l l997-08-06 less waste of material. Nevertheless, a circular cross section is advantageous when an array of several sources and/or deLe-Lols is used in the optical system.Since contamination is possible if excess sample were to drop from the disposable, it is desirable to accommodate large samples, without dripping.
Various designs can serve to retain excess sample. One is shown in Figs. 12, 13,and 14. Fig. 12 depicts the disposable of Fig. 11 with indentations 124 on the small-end surface of the disposable. As shown in Figs. 13 and 14, the indentations allow capillary flow to fill the resulting gap between the membrane and the top inside surface of the device. An alternative way of forming such gaps is to adhere the membrane to the disposable with thick adhesive, leaving gaps to accommodate the excess sample. Another way to absorb excess sample is to attach an absorbent pad 126 over the front surface ofthe membrane, as shown in Fig. 15.
Fig. 16 is an exploded perspective view of a meter and a disposable of the type shown in Fig. 11. The distal section 132 of meter 130 has an optional groove 134, which is similar to groove 34, for retaining the disposable.
Elongated neck 130 facilitates pickup of disposables from the elongated containers 42 shown in Fig. 6. Display 150 depicts the measured analyte concentration.
Fig. 17 depicts an alternative embodiment of a meter adapted for use with the disposable of Fig. 11.
Fig. 18 depicts the distal portion of yet another embodiment of a disposable 210 and meter 230. Distal section 232 mates with disposable 210.

Note that slots 234 are an alternative to groove 34 (or 134) for capturing indentations, such as 220, on the disposable.
Fig. 19 is a side view of the embodiment of Fig. 18.
In the method of this invention, a blood sample is picked up on the S outward-facing surface of the membrane. Glucose in the sample interacts with a reagent in the membrane to cause a color change, which changes the reflectance of the inward-facing membrane surface. The light source in the meter illuminates the inward-facing membrane surface and measures the intensity of light reflected from that surface. Using the appropriate computation, the change in reflectance yields the glucose concentration in the sample.
A variety of combinations of membrane and reagent compositions are known for photometric determinations of blood glucose concentration. A
preferred membrane/reagent composition is a polyamide matrix incol~orating an oxidase enzyme, a peroxidase, and a dye or dye couple. The oxidase enzyme is ~rererdbly glucose oxidase. The peroxidase is pierelably horseradish peroxidase. A preferred dye couple is 3-methyl-2 benzothiazolinone hydrazone hydrochloride plus 3,3-dimethylaminobenzoic acid. Details of that membrane/reagent combination and variations on it appear in U.S. Pat. 5,304,468, issued April 19, 1994, to Phillips et al., incorporated herein by refefence.
Another ~rere~led membrane/reagent composition is an anisotropic polysulfone membrane (available from Memtec America Corp., Timonium, MD) incorporating glucose oxidase, horseradish peroxidase, and the dye couple [3-methyl-2-benzothiazolinone hydrazone] N-sulfonyl benzenesulfonate monosodium combined with 8-anilino-1-naphthalene sulfonic acid ammonium.

Details of that membrane/reagent combination and variations on it appear in U.S. Pat. Appl. Ser. No. 08/302,575, filed September 8,1994, incorporated herein by referellce.
It will be understood by those skilled in the art that the foregoing S descriptions of embodiments of this invention are illustrative of practicing the present invention but are in no way limiting. Variations of the detail presentedherein may be made without departing from the scope and spirit of the present invention.

Claims (7)

1. A method for measuring a concentration of an analyte in a sample of a biological fluid comprising (a) providing a device that comprises a hollow frustum having open ends of unequal size, whose smaller end is substantially closed by a membrane that has (ii) a first surface for accepting the sample and (ii) a reagent for reacting with the analyte to cause, in a physically detectable parameter of the membrane, a change that can be measured and be related to the concentration of the analyte in the sample;
(b) applying the sample to the first surface;
(c) measuring the change in the parameter; and (d) determining the analyte concentration from the measurement of the parameter change.
2. The method of claim 1 in which the device is provided on an end of an elongated meter, which both supports the device and measures the parameter change.
3. The method of claim 2 in which the elongated meter has a frustum-shaped distal section for mating engagement with the device for making the measurement.
4. The method of claim 3 in which providing the device on the end of the meter comprises removably engaging a peripheral groove on the distal section of the meter with indentations on a perimeter of the device, without a user directly contacting the device.
5. The method of claim 1 in which the reagent reacts with the analyte to cause a color change, and the membrane parameter whose change is measured is a reflectance of a second surface, opposite to the first surface.
6. The method of claim 5 in which the sample is whole blood and the analyte is blood glucose.
7. The method of claim 1 further comprising the step of removing the device from the meter, without directly contacting the device.
CA002212601A 1996-08-09 1997-08-06 Analyte concentration measurement using a hollow frustum Abandoned CA2212601A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/694,972 US5753429A (en) 1996-08-09 1996-08-09 Analyte concentration measurement using a hollow frustum
US08/694,972 1996-08-09

Publications (1)

Publication Number Publication Date
CA2212601A1 true CA2212601A1 (en) 1998-02-09

Family

ID=24791046

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002212601A Abandoned CA2212601A1 (en) 1996-08-09 1997-08-06 Analyte concentration measurement using a hollow frustum

Country Status (21)

Country Link
US (1) US5753429A (en)
EP (1) EP0823634B1 (en)
JP (1) JPH10132813A (en)
KR (1) KR100562179B1 (en)
CN (1) CN1125339C (en)
AR (1) AR009047A1 (en)
AT (1) ATE260465T1 (en)
AU (1) AU712523B2 (en)
BR (1) BR9704296A (en)
CA (1) CA2212601A1 (en)
DE (1) DE69727737T2 (en)
DK (1) DK0823634T3 (en)
ES (1) ES2215213T3 (en)
HK (1) HK1004420A1 (en)
IL (1) IL121482A (en)
MY (1) MY116949A (en)
NO (1) NO320168B1 (en)
PT (1) PT823634E (en)
RU (1) RU2201595C2 (en)
SG (1) SG73465A1 (en)
TW (1) TW355677B (en)

Families Citing this family (80)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6391005B1 (en) 1998-03-30 2002-05-21 Agilent Technologies, Inc. Apparatus and method for penetration with shaft having a sensor for sensing penetration depth
JP3654786B2 (en) 1999-02-08 2005-06-02 テルモ株式会社 Component measurement chip
US6458326B1 (en) 1999-11-24 2002-10-01 Home Diagnostics, Inc. Protective test strip platform
US8641644B2 (en) 2000-11-21 2014-02-04 Sanofi-Aventis Deutschland Gmbh Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means
US6525330B2 (en) 2001-02-28 2003-02-25 Home Diagnostics, Inc. Method of strip insertion detection
US6541266B2 (en) 2001-02-28 2003-04-01 Home Diagnostics, Inc. Method for determining concentration of an analyte in a test strip
US6562625B2 (en) 2001-02-28 2003-05-13 Home Diagnostics, Inc. Distinguishing test types through spectral analysis
US9795747B2 (en) 2010-06-02 2017-10-24 Sanofi-Aventis Deutschland Gmbh Methods and apparatus for lancet actuation
US8337419B2 (en) 2002-04-19 2012-12-25 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US7025774B2 (en) 2001-06-12 2006-04-11 Pelikan Technologies, Inc. Tissue penetration device
US7316700B2 (en) 2001-06-12 2008-01-08 Pelikan Technologies, Inc. Self optimizing lancing device with adaptation means to temporal variations in cutaneous properties
US9226699B2 (en) 2002-04-19 2016-01-05 Sanofi-Aventis Deutschland Gmbh Body fluid sampling module with a continuous compression tissue interface surface
US7749174B2 (en) 2001-06-12 2010-07-06 Pelikan Technologies, Inc. Method and apparatus for lancet launching device intergrated onto a blood-sampling cartridge
US7981056B2 (en) 2002-04-19 2011-07-19 Pelikan Technologies, Inc. Methods and apparatus for lancet actuation
DE60238119D1 (en) 2001-06-12 2010-12-09 Pelikan Technologies Inc ELECTRIC ACTUATOR ELEMENT FOR A LANZETTE
US9427532B2 (en) 2001-06-12 2016-08-30 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US6723500B2 (en) * 2001-12-05 2004-04-20 Lifescan, Inc. Test strips having reaction zones and channels defined by a thermally transferred hydrophobic barrier
US6872358B2 (en) 2002-01-16 2005-03-29 Lifescan, Inc. Test strip dispenser
US7232451B2 (en) 2002-04-19 2007-06-19 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US9248267B2 (en) 2002-04-19 2016-02-02 Sanofi-Aventis Deustchland Gmbh Tissue penetration device
US7713214B2 (en) 2002-04-19 2010-05-11 Pelikan Technologies, Inc. Method and apparatus for a multi-use body fluid sampling device with optical analyte sensing
US7976476B2 (en) 2002-04-19 2011-07-12 Pelikan Technologies, Inc. Device and method for variable speed lancet
US8372016B2 (en) 2002-04-19 2013-02-12 Sanofi-Aventis Deutschland Gmbh Method and apparatus for body fluid sampling and analyte sensing
US8579831B2 (en) 2002-04-19 2013-11-12 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US8784335B2 (en) 2002-04-19 2014-07-22 Sanofi-Aventis Deutschland Gmbh Body fluid sampling device with a capacitive sensor
US7547287B2 (en) 2002-04-19 2009-06-16 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8360992B2 (en) 2002-04-19 2013-01-29 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US9795334B2 (en) 2002-04-19 2017-10-24 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7909778B2 (en) 2002-04-19 2011-03-22 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7491178B2 (en) 2002-04-19 2009-02-17 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US9314194B2 (en) 2002-04-19 2016-04-19 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US7175642B2 (en) 2002-04-19 2007-02-13 Pelikan Technologies, Inc. Methods and apparatus for lancet actuation
US7674232B2 (en) 2002-04-19 2010-03-09 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7297122B2 (en) 2002-04-19 2007-11-20 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7229458B2 (en) 2002-04-19 2007-06-12 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7331931B2 (en) 2002-04-19 2008-02-19 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8221334B2 (en) 2002-04-19 2012-07-17 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7892183B2 (en) 2002-04-19 2011-02-22 Pelikan Technologies, Inc. Method and apparatus for body fluid sampling and analyte sensing
US7901362B2 (en) 2002-04-19 2011-03-08 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8267870B2 (en) 2002-04-19 2012-09-18 Sanofi-Aventis Deutschland Gmbh Method and apparatus for body fluid sampling with hybrid actuation
US8702624B2 (en) 2006-09-29 2014-04-22 Sanofi-Aventis Deutschland Gmbh Analyte measurement device with a single shot actuator
US7343188B2 (en) * 2002-05-09 2008-03-11 Lifescan, Inc. Devices and methods for accessing and analyzing physiological fluid
US20030212344A1 (en) * 2002-05-09 2003-11-13 Vadim Yuzhakov Physiological sample collection devices and methods of using the same
US20030223906A1 (en) * 2002-06-03 2003-12-04 Mcallister Devin Test strip container system
US8574895B2 (en) 2002-12-30 2013-11-05 Sanofi-Aventis Deutschland Gmbh Method and apparatus using optical techniques to measure analyte levels
US8262614B2 (en) 2003-05-30 2012-09-11 Pelikan Technologies, Inc. Method and apparatus for fluid injection
US7850621B2 (en) 2003-06-06 2010-12-14 Pelikan Technologies, Inc. Method and apparatus for body fluid sampling and analyte sensing
WO2006001797A1 (en) 2004-06-14 2006-01-05 Pelikan Technologies, Inc. Low pain penetrating
WO2005033659A2 (en) 2003-09-29 2005-04-14 Pelikan Technologies, Inc. Method and apparatus for an improved sample capture device
EP1680014A4 (en) 2003-10-14 2009-01-21 Pelikan Technologies Inc Method and apparatus for a variable user interface
US8668656B2 (en) 2003-12-31 2014-03-11 Sanofi-Aventis Deutschland Gmbh Method and apparatus for improving fluidic flow and sample capture
US7822454B1 (en) 2005-01-03 2010-10-26 Pelikan Technologies, Inc. Fluid sampling device with improved analyte detecting member configuration
WO2006011062A2 (en) 2004-05-20 2006-02-02 Albatros Technologies Gmbh & Co. Kg Printable hydrogel for biosensors
EP1765194A4 (en) 2004-06-03 2010-09-29 Pelikan Technologies Inc Method and apparatus for a fluid sampling device
US9775553B2 (en) 2004-06-03 2017-10-03 Sanofi-Aventis Deutschland Gmbh Method and apparatus for a fluid sampling device
US8652831B2 (en) 2004-12-30 2014-02-18 Sanofi-Aventis Deutschland Gmbh Method and apparatus for analyte measurement test time
BRPI0613592A2 (en) * 2005-07-20 2011-01-18 Bayer Healthcare Llc port-connected amperometry
WO2007108519A1 (en) * 2006-03-22 2007-09-27 Matsushita Electric Industrial Co., Ltd. Blood test apparatus
JP4871083B2 (en) * 2006-09-27 2012-02-08 テルモ株式会社 Body fluid collection unit
WO2008136472A1 (en) * 2007-04-29 2008-11-13 Arkray, Inc. Analyzing system
WO2009108239A2 (en) * 2007-12-10 2009-09-03 Bayer Healthcare Llc Slope-based compensation
US8152195B2 (en) * 2008-03-10 2012-04-10 Hendrickson Usa, Llc Modular suspension system and components thereof
US8302988B2 (en) 2008-03-10 2012-11-06 Hendrickson Usa, L.L.C. Suspension assembly with tie-plate
US7926836B2 (en) 2008-03-10 2011-04-19 Hendrickson Usa, Llc. Elastomeric spring vehicle suspension
US8052166B2 (en) * 2008-03-10 2011-11-08 Hendrickson Usa, Llc. Tie-plate and frame hanger of a suspension assembly
EP2265324B1 (en) 2008-04-11 2015-01-28 Sanofi-Aventis Deutschland GmbH Integrated analyte measurement system
DK2138233T3 (en) * 2008-06-02 2011-01-31 Boehringer Ingelheim Micropart Microfluidic film structure for dosing liquids
US9375169B2 (en) 2009-01-30 2016-06-28 Sanofi-Aventis Deutschland Gmbh Cam drive for managing disposable penetrating member actions with a single motor and motor and control system
USD633011S1 (en) 2009-06-02 2011-02-22 Hendrickson Usa, L.L.C. Suspension assembly
US8965476B2 (en) 2010-04-16 2015-02-24 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
USD672286S1 (en) 2010-09-05 2012-12-11 Hendrickson Usa, L.L.C. Suspension assembly
WO2013009626A1 (en) 2011-07-08 2013-01-17 Hendrickson Usa, Llc Vehicle suspension and improved method of assembly
US8262112B1 (en) 2011-07-08 2012-09-11 Hendrickson Usa, L.L.C. Vehicle suspension and improved method of assembly
US9004512B2 (en) 2011-07-08 2015-04-14 Hendrickson Usa, L.L.C. Shear spring useful for vehicle suspension
USD700112S1 (en) 2012-07-06 2014-02-25 Hendrickson Usa, L.L.C. Progressive rate spring for a suspension
USD700113S1 (en) 2012-07-06 2014-02-25 Hendrickson Usa, L.L.C. Suspension assembly
US9085212B2 (en) 2013-03-15 2015-07-21 Hendrickson Usa, L.L.C. Vehicle suspension
US9150071B2 (en) 2013-07-25 2015-10-06 Hendrickson Usa, L.L.C. Frame hanger for vehicle suspension
EP2835639B1 (en) * 2013-08-09 2020-01-01 Roche Diabetes Care GmbH Test tape device and operating method
CN106574929B (en) 2014-07-25 2019-08-09 贝克顿·迪金森公司 Analyte testing item test and for its implement test-strips and kit

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3992158A (en) * 1973-08-16 1976-11-16 Eastman Kodak Company Integral analytical element
FR2287941A1 (en) * 1974-10-15 1976-05-14 Marteau D Autry Eric DEVICE FOR EJECTING THE REMOVABLE TIP OF A PIPETTE
US4627445A (en) * 1985-04-08 1986-12-09 Garid, Inc. Glucose medical monitoring system
US4935346A (en) * 1986-08-13 1990-06-19 Lifescan, Inc. Minimum procedure system for the determination of analytes
US4874691A (en) * 1987-10-16 1989-10-17 Quadra Logic Technologies Inc. Membrane-supported immunoassays
US4952373A (en) * 1989-04-21 1990-08-28 Biotrack, Inc. Liquid shield for cartridge
US5100620A (en) * 1989-05-15 1992-03-31 Miles, Inc. Capillary tube/gap reagent format
US5234813A (en) * 1989-05-17 1993-08-10 Actimed Laboratories, Inc. Method and device for metering of fluid samples and detection of analytes therein
IE75720B1 (en) * 1990-10-08 1997-09-24 Akzo Nv Device for performing a rapid single manual assay
DE4227678A1 (en) * 1992-08-21 1994-02-24 Boehringer Mannheim Gmbh Light-guiding analysis element for the determination of an analyte
EP0588564B1 (en) * 1992-09-18 1996-11-13 AMERSHAM INTERNATIONAL plc Device and method for affinity separation
DE4326339A1 (en) * 1993-08-05 1995-02-09 Boehringer Mannheim Gmbh System for analysis of sample liquids
US5563031A (en) * 1994-09-08 1996-10-08 Lifescan, Inc. Highly stable oxidative coupling dye for spectrophotometric determination of analytes
AU2122895A (en) * 1995-03-16 1996-10-16 Health Craft International, Inc. Apparatus for monitoring glucose level
US6660233B1 (en) * 1996-01-16 2003-12-09 Beckman Coulter, Inc. Analytical biochemistry system with robotically carried bioarray

Also Published As

Publication number Publication date
AR009047A1 (en) 2000-03-08
SG73465A1 (en) 2000-06-20
KR100562179B1 (en) 2006-08-31
AU3320897A (en) 1998-02-12
DK0823634T3 (en) 2004-06-01
MY116949A (en) 2004-04-30
CN1178904A (en) 1998-04-15
EP0823634A2 (en) 1998-02-11
ATE260465T1 (en) 2004-03-15
RU2201595C2 (en) 2003-03-27
CN1125339C (en) 2003-10-22
EP0823634B1 (en) 2004-02-25
ES2215213T3 (en) 2004-10-01
KR19980018609A (en) 1998-06-05
NO320168B1 (en) 2005-11-07
NO973662D0 (en) 1997-08-08
IL121482A (en) 2000-08-31
EP0823634A3 (en) 2000-03-15
BR9704296A (en) 1999-04-06
MX9706103A (en) 1998-05-31
PT823634E (en) 2004-07-30
NO973662L (en) 1998-02-10
IL121482A0 (en) 1998-02-08
DE69727737T2 (en) 2009-09-24
TW355677B (en) 1999-04-11
HK1004420A1 (en) 1998-11-27
JPH10132813A (en) 1998-05-22
AU712523B2 (en) 1999-11-11
US5753429A (en) 1998-05-19
DE69727737D1 (en) 2004-04-01

Similar Documents

Publication Publication Date Title
EP0823634B1 (en) Analyte concentration measurement using a hollow frustum
US5736103A (en) Remote-dosing analyte concentration meter
US5846486A (en) Hollow frustum reagent test device
US6099802A (en) Hollow frustum reagent test device
AU688979B2 (en) Analyte detection strip with orientation index
US20120165626A1 (en) Devices, methods, and kits for determining analyte concentrations
MXPA97006102A (en) Hollow troncoconic device for pru reagents
MXPA97006103A (en) Measurement of analytic concentration through the use of a hu troncoconic device
MXPA97006104A (en) Concentration meter of analytics by remote

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued